Clinical trial
Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension
NCT05277870 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension
- Lead sponsor
- University of Washington
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2022
- Completion date
- June 30, 2025
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.